{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:03:23Z","timestamp":1780117403729,"version":"3.54.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00162","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T05:54:11Z","timestamp":1588139651000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Intravenous Cyclophosphamide in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. An Open-Label Phase II Study"],"prefix":"10.3389","volume":"7","author":[{"given":"Ingrid G.","family":"Rekeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Foss\u00e5","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgeir","family":"Lande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irini","family":"Ktoridou-Valen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"S\u00f8rland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Holsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Tronstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Risa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kine","family":"Alme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marte K.","family":"Viken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte A.","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Mella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Fluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1177\/1359105318784161","article-title":"Meta-analysis investigating post-exertional malaise between patients and controls","author":"Brown","year":"2018","journal-title":"J Health Psychol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0197811","DOI":"10.1371\/journal.pone.0197811","article-title":"Deconstructing post-exertional malaise in myalgic encephalomyelitis\/ chronic fatigue syndrome: a patient-centered, cross-sectional survey","volume":"13","author":"Chu","year":"2018","journal-title":"PLoS ONE."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e12703","DOI":"10.1111\/jsr.12703","article-title":"Poor self-reported sleep quality and health-related quality of life in patients with chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"27","author":"Castro-Marrero","year":"2018","journal-title":"J Sleep Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1300\/J092v11n01_02","article-title":"Myalgic encephalomyelitis\/ chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols","volume":"11","author":"Carruthers","year":"2003","journal-title":"J Chronic Fatigue Syndr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1741-7015-9-91","article-title":"Prevalence of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) in three regions of England: a repeated cross-sectional study in primary care","volume":"9","author":"Nacul","year":"2011","journal-title":"BMC Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0132421","DOI":"10.1371\/journal.pone.0132421","article-title":"The health-related quality of life for patients with myalgic encephalomyelitis \/ chronic fatigue syndrome (ME\/CFS)","volume":"10","author":"Falk Hvidberg","year":"2015","journal-title":"PLoS ONE."},{"key":"B7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/1471-2458-11-402","article-title":"The functional status and well being of people with myalgic encephalomyelitis\/chronic fatigue syndrome and their carers","volume":"11","author":"Nacul","year":"2011","journal-title":"BMC Public Health"},{"key":"B8","volume-title":"The National Academies Collection: Reports funded by National Institutes of Health. Beyond Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Redefining an Illness","year":"2015"},{"key":"B9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fimmu.2018.00229","article-title":"Infection elicited autoimmunity and myalgic encephalomyelitis\/chronic fatigue syndrome: an explanatory model","volume":"9","author":"Blomberg","year":"2018","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10067-018-4009-2","article-title":"On chronic fatigue syndrome and nosological categories","volume":"37","author":"Sharif","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12035-013-8553-0","article-title":"The emerging role of autoimmunity in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"49","author":"Morris","year":"2014","journal-title":"Mol Neurobiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome - evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"E7150","DOI":"10.1073\/pnas.1710519114","article-title":"Cytokine signature associated with disease severity in chronic fatigue syndrome patients","volume":"114","author":"Montoya","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/intimm\/dxt068","article-title":"Role of adaptive and innate immune cells in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"26","author":"Brenu","year":"2014","journal-title":"Int Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0193672","DOI":"10.1371\/journal.pone.0193672","article-title":"Immunoadsorption to remove beta2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS\/ME","volume":"13","author":"Scheibenbogen","year":"2018","journal-title":"PLoS ONE."},{"key":"B16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbi.2015.09.013","article-title":"Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome","volume":"52","author":"Loebel","year":"2016","journal-title":"Brain Behav Immun."},{"key":"B17","first-page":"225","article-title":"Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome","volume":"12","author":"Tanaka","year":"2003","journal-title":"Int J Mol Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1007\/s12035-018-1354-8","article-title":"Immunosignature analysis of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"56","author":"Gunther","year":"2019","journal-title":"Mol Neurobiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5929","DOI":"10.1002\/cncr.27612","article-title":"Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults","volume":"118","author":"Chang","year":"2012","journal-title":"Cancer."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e89376","DOI":"10.1172\/jci.insight.89376","article-title":"Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy\/chronic fatigue syndrome","volume":"1","author":"Fluge","year":"2016","journal-title":"JCI Insight."},{"key":"B21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1039\/C6MB00600K","article-title":"Metabolic profiling of a myalgic encephalomyelitis\/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism","volume":"13","author":"Germain","year":"2017","journal-title":"Mol Biosyst."},{"key":"B22","doi-asserted-by":"publisher","first-page":"34990","DOI":"10.1038\/srep34990","article-title":"Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles","volume":"6","author":"Yamano","year":"2016","journal-title":"Sci Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"E5472","DOI":"10.1073\/pnas.1607571113","article-title":"Metabolic features of chronic fatigue syndrome","volume":"113","author":"Naviaux","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10056","DOI":"10.1038\/s41598-018-28477-9","article-title":"Insights into myalgic encephalomyelitis\/chronic fatigue syndrome phenotypes through comprehensive metabolomics","volume":"8","author":"Nagy-Szakal","year":"2018","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2377-11-62","article-title":"Evidence for a heritable predisposition to Chronic Fatigue Syndrome","volume":"11","author":"Albright","year":"2011","journal-title":"BMC Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1375\/twin.10.5.729","article-title":"Twin analyses of fatigue","volume":"10","author":"Schur","year":"2007","journal-title":"Twin Res Hum Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1093\/clinids\/18.Supplement_1.S154","article-title":"Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome","volume":"18","author":"Keller","year":"1994","journal-title":"Clin Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1177\/039463200902200320","article-title":"Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome","volume":"22","author":"Carlo-Stella","year":"2009","journal-title":"Int J Immunopathol Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1136\/jcp.2004.022681","article-title":"Association of chronic fatigue syndrome with human leucocyte antigen class II alleles","volume":"58","author":"Smith","year":"2005","journal-title":"J Clin Pathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1038\/s41598-020-62157-x","article-title":"Human leucocyte antigen alleles associated with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS)","volume":"10","author":"Lande","year":"2020","journal-title":"Sci Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fonc.2018.00163","article-title":"Past, present, and future of rituximab-the world's first oncology monoclonal antibody therapy","volume":"8","author":"Pierpont","year":"2018","journal-title":"Front Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0129898","DOI":"10.1371\/journal.pone.0129898","article-title":"B-Lymphocyte depletion in myalgic encephalopathy\/ chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment","volume":"10","author":"Fluge","year":"2015","journal-title":"PLoS ONE."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e26358","DOI":"10.1371\/journal.pone.0026358","article-title":"Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study","volume":"6","author":"Fluge","year":"2011","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2377-9-28","article-title":"Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series","volume":"9","author":"Fluge","year":"2009","journal-title":"BMC Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.7326\/M18-1451","article-title":"B-lymphocyte depletion in patients with myalgic encephalomyelitis\/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial","volume":"170","author":"Fluge","year":"2019","journal-title":"Ann Intern Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat Rev Clin Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ejim.2013.02.008","article-title":"Using cyclophosphamide in inflammatory rheumatic diseases","volume":"24","author":"Brummaier","year":"2013","journal-title":"Eur J Intern Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/rheumatology\/keh082","article-title":"Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety","volume":"43","author":"Riley","year":"2004","journal-title":"Rheumatology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"961702","DOI":"10.4061\/2011\/961702","article-title":"Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis","volume":"2011","author":"Patti","year":"2011","journal-title":"Autoimmune Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0733-8635(05)70194-7","article-title":"Pulse intravenous cyclophosphamide therapy for dermatologic disorders","volume":"18","author":"Fox","year":"2000","journal-title":"Dermatol Clin."},{"key":"B41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","article-title":"The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy","volume":"78","author":"Ahlmann","year":"2016","journal-title":"Cancer Chemother Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jama.292.10.1195","article-title":"Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial","volume":"292","author":"Blacker","year":"2004","journal-title":"JAMA."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S0895-4356(98)00098-5","article-title":"Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity","volume":"51","author":"Loge","year":"1998","journal-title":"J Clin Epidemiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care."},{"key":"B45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/14034940410028406","article-title":"Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale","volume":"33","author":"Lerdal","year":"2005","journal-title":"Scand J Public Health."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2522\/ptj.20100291","article-title":"Physical activity measured by the SenseWear Armband in women with rheumatoid arthritis","volume":"91","author":"Almeida","year":"2011","journal-title":"Phys Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00421-011-2131-9","article-title":"Variability in physical activity patterns as measured by the SenseWear Armband: how many days are needed?","volume":"112","author":"Scheers","year":"2012","journal-title":"Eur J Appl Physiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/jnci\/djj243","article-title":"Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"98","author":"Sklar","year":"2006","journal-title":"J Natl Cancer Inst."},{"key":"B50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bpobgyn.2018.06.010","article-title":"Conservative management of reproductive cancers. Ovarian protection during treatment","volume":"55","author":"Cui","year":"2019","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"355.e325","DOI":"10.1016\/j.amjmed.2005.08.045","article-title":"Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide","volume":"119","author":"Mok","year":"2006","journal-title":"Am J Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1200\/JCO.2015.65.8864","article-title":"No Evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial","volume":"34","author":"Demeestere","year":"2016","journal-title":"J Clin Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","article-title":"Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project","volume":"51","author":"Ware","year":"1998","journal-title":"J Clin Epidemiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/cei.12696","article-title":"Polymorphisms within the human leucocyte antigen-E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy","volume":"182","author":"Iwaszko","year":"2015","journal-title":"Clin Exp Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.jaci.2018.11.038","article-title":"HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis","volume":"143","author":"Dand","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1182\/blood.V84.12.4257.bloodjournal84124257","article-title":"Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia","volume":"84","author":"Nakao","year":"1994","journal-title":"Blood."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2215\/CJN.13071211","article-title":"Association of HLA genes with clinical outcomes of ANCA-associated vasculitis","volume":"7","author":"Chang","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fped.2019.00012","article-title":"Onset patterns and course of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"7","author":"Chu","year":"2019","journal-title":"Front Pediatr."},{"key":"B59","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/01.psy.0000156969.76986.e0","article-title":"The placebo response in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis","volume":"67","author":"Cho","year":"2005","journal-title":"Psychosom Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40122-017-0071-8","article-title":"Why we should assess patients' expectations in clinical trials","volume":"6","author":"Frisaldi","year":"2017","journal-title":"Pain Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0268-960X(92)90028-O","article-title":"Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies","volume":"6","author":"Hall","year":"1992","journal-title":"Blood Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"Cd010908","DOI":"10.1002\/14651858.CD010908.pub2","article-title":"Cyclophosphamide for connective tissue disease-associated interstitial lung disease","volume":"1","author":"Barnes","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-3083.2009.02308.x","article-title":"How do regulatory T cells work?","volume":"70","author":"Corthay","year":"2009","journal-title":"Scand J Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"300","DOI":"10.12932\/AP0733","article-title":"Regulatory T, natural killer T and gammadelta T cells in multiple sclerosis and chronic fatigue syndrome\/myalgic encephalomyelitis: a comparison","volume":"34","author":"Ramos","year":"2016","journal-title":"Asian Pac J Allergy Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1479-5876-11-68","article-title":"Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome","volume":"11","author":"Curriu","year":"2013","journal-title":"J Transl Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1479-5876-9-81","article-title":"Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis","volume":"9","author":"Brenu","year":"2011","journal-title":"J Transl Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1084\/jem.20040168","article-title":"Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB\/W mice","volume":"199","author":"Hoyer","year":"2004","journal-title":"J Exp Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cnp.2020.01.003","article-title":"Cerebral blood flow is reduced in ME\/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography","volume":"5","author":"van Campen","year":"2020","journal-title":"Clin Neurophysiol Pract."},{"key":"B69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1086\/685054","article-title":"Unexplained exertional dyspnea caused by low ventricular filling pressures: results from clinical invasive cardiopulmonary exercise testing","volume":"6","author":"Oldham","year":"2016","journal-title":"Pulm Circ."},{"key":"B70","first-page":"A6902","article-title":"The patophysiology of Chronic Fatigue Syndrome: Results from an invasive cardiopulmonary exercise laboratory","volume":"199","author":"Joseph","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00421-019-04222-6","article-title":"Unexplained exertional intolerance associated with impaired systemic oxygen extraction","volume":"119","author":"Melamed","year":"2019","journal-title":"Eur J Appl Physiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jamaneurol.2019.2917","article-title":"Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review","volume":"76","author":"Oaklander","year":"2019","journal-title":"JAMA Neurol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.semarthrit.2018.08.003","article-title":"A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis","volume":"48","author":"Grayston","year":"2019","journal-title":"Semin Arthritis Rheum."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s11306-015-0816-5","article-title":"Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients","volume":"11","author":"Armstrong","year":"2015","journal-title":"Metabolomics."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e14138","DOI":"10.14814\/phy2.14138","article-title":"Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"7","author":"Lien","year":"2019","journal-title":"Physiol Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijcard.2011.10.030","article-title":"Large and small artery endothelial dysfunction in chronic fatigue syndrome","volume":"154","author":"Newton","year":"2012","journal-title":"Int J Cardiol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00162\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T05:54:15Z","timestamp":1588139655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00162\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":76,"alternative-id":["10.3389\/fmed.2020.00162"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00162","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"article-number":"162"}}